title: Open-label phase II trial of recombinant beta interferon (IFN-beta (ser)) in patients with colorectal cancer.
authors.affiliation: Department of Internal Medicine, Ohio State University Comprehensive Cancer Center, Columbus.
authors.forename: P L
authors.initials: PL
authors.lastname: Triozzi
authors.forename: P
authors.initials: P
authors.lastname: Kenney
authors.forename: D
authors.initials: D
authors.lastname: Young
authors.forename: J J
authors.initials: JJ
authors.lastname: Rinehart
mesh_terms: D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D003110:Colonic Neoplasms / Q000628:therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007370:Interferon Type I / Q000009:adverse effects / Q000627:therapeutic use*; D000068556:Interferon beta-1a; D000068576:Interferon beta-1b; D016899:Interferon-beta; D008113:Liver Neoplasms / Q000556:secondary; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use*; D012004:Rectal Neoplasms / Q000628:therapy*
chemical_list: D007370:Interferon Type I; D011994:Recombinant Proteins; D000068576:Interferon beta-1b; D016899:Interferon-beta; D000068556:Interferon beta-1a